Clinical Advances in
Read Overview
Supported by an independent educational grant from
Actelion Pharmaceuticals Ltd,
a Janssen pharmaceutical company of Johnson & Johnson
Associate Professor
Director, CTEPH Program
Associate Director, Pulmonary Hypertension Program
Professor
Mater Misericordiae University Hospital
University College Dublin
Dublin, Ireland
Professor of Pulmonary Vascular Medicine
Medical Executive Director
Kerckhoff-Klinik GmbH, Bad Nauheim
Hesse, Germany
Consultant Respiratory Physician
Director, National Pulmonary Vascular Disease Unit
Royal Papworth Hospital
NHS Foundation Trust
Cambridge, United Kingdom
Professor of Medicine
Head of the Lung Transplant and Pulmonary Hypertension Programs
UT Southwestern Medical Center
Dallas, Texas, United States
Associate Professor
Lund University
Head, Swedish Association of Pulmonary Hypertension
Lund, Sweden